ZELTIQ(R) Aesthetics Showcasing New CoolSmooth PRO(TM) Applicator at American Academy of Dermatology Annual Meeting

PLEASANTON, CA -- (Marketwired) -- 03/19/15 -- ZELTIQ� Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is showcasing its CoolSmooth PRO" applicator, a second generation surface applicator featuring non-vacuum based cooling to treat non-pinchable fat bulges such as the outer thigh area, at the American Academy of Dermatology (AAD) Annual Meeting in San Francisco, March 20-24, 2015.

A live CoolSmooth PRO demonstration will be performed during the panel entitled "Sculpt a New Vision of Your Practice with CoolSculpting®." Medical aesthetic experts Drs. Suzanne Kilmer, Elizabeth Tanzi, Nick Lowe and Jill Waibel will be speaking about how the CoolSculpting procedure has revolutionized their practices. The panel takes on Sunday, March 22, at 6:30 p.m. in the Yerba Buena Room of the Four Seasons Hotel.

Earlier this year the company received Food and Drug Administration (FDA) clearance to perform the CoolSculpting® procedure at lower temperatures, enabling shorter treatment times. The new treatment parameters are initially being offered with the CoolSmooth PRO applicator, which also includes an enhanced strapping system that provides increased conformity at the treatment site, while also improving ease of use and patient comfort. ZELTIQ plans to offer current CoolSmooth customers an exchange program to facilitate access to the new technology.

To learn more about the CoolSmooth PRO applicator and the CoolSculpting procedure, visit ZELTIQ at AAD booth 2506 in Moscone Center South during exhibit hours on March 21-March 23, 2015, 10 a.m. to 5 p.m.

About the CoolSculpting® Procedure The CoolSculpting procedure is a non-surgical, clinically proven procedure that selectively reduces fat bulges in problem areas using a patented cooling technology. Cleared by the FDA for noninvasive fat reduction in the abdomen, flank and thighs, it gently cools unwanted fat cells in the body to induce a natural, controlled elimination of fat cells without harming surrounding tissue, and the treated fat cells are gone for good. More than 1.5 million CoolSculpting treatments have been performed in over 70 countries around the world. The CoolSculpting procedure is available through an elite network of CoolSculpting Centers worldwide. Dermatologists, plastic surgeons and leading aesthetic specialists that offer the CoolSculpting procedure can be found at www.coolsculpting.com. Be sure to follow the CoolSculpting procedure on Facebook, Twitter, Pinterest and YouTube.

About ZELTIQ® Aesthetics, Inc. ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® system, is designed to selectively reduce stubborn fat that may not respond to diet or exercise. The CoolSculpting procedure is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed the CoolSculpting procedure to safely, noticeably, and measurably reduce the fat layer.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2786858 Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2786861 Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2786864

Source: ZELTIQ Aesthetics, Inc.

You May Also Be Interested In

• Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
• InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 26
• Medigene AG reports Financial Results and Business Update for Q1 2024